I-Mab ( IMAB) - Key Metrics
Stock symbol IMAB is outdated, potentially delisted? Maybe it is available on other exchange?
IMAB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q4 | ? | -$0.05 | ? | ? |
| 2024Q3 | ? | -$0.11 | ? | ? |
| 2024Q2 | ? | $0.13 | ? | ? |
| 2024Q1 | ? | $0.11 | ? | ? |
| 2023Q4 | $0.02 | -$1.81 | ? | ? |
IMAB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q4 | ? | -1.91 |
| 2024Q3 | ? | -8.65 |
| 2024Q2 | ? | 9.58 |
| 2024Q1 | ? | 12.88 |
| 2023Q4 | ? | -0.81 |
IMAB Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2024Q4 | ? | ? |
| 2024Q3 | ? | ? |
| 2024Q2 | ? | ? |
| 2024Q1 | ? | ? |
| 2023Q4 | ? | ? |
IMAB
Price: $4.63
52 week price:
Earnings Per Share: -0.51 USD
P/E Ratio: -9.08
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: China
Volume: 425462
Market Capitalization: 378.9 million